π PRICE TARGET RAISED
β’ $NVDA: PT raised to $320 from $280 by JPMorgan
β’ $NVDA: PT raised to $315 from $300 by Mizuho
β’ $NVDA: PT raised to $420 from $400 by Melius
β’ $NVDA: PT raised to $300 from $285 by Goldman Sachs
β’ $NVDA: PT raised to $400 from $315 by Bernstein SocGen Group
β’ $NVDA: PT raised to $315 from $300 by Citi
β’ $NVDA: PT raised to $315 from $282 by Stifel
π΅ COVERAGE
β’ $NVDA: Overweight reiterated by KeyBanc; PT $330
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
